GSK554418A(871819-90-8)
- Name: GSK554418A
- Synonyms:
- Molecular Formula:
- Molecular Weight:
- CAS Registry Number:871819-90-8
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.871819-90-8 GSK554418A
Assay:98% Appearance:Powder Package:inquiry Storage:-20鈩?Freezer Transportation:inquiry Application:GSK-554418A is a azaindole Cannabinoid receptor type 2 (CB2) agonist. It can be used for the treatment of chronic pain.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 226393-68-6/SC-276
- 226395-57-9/SC-77774
- 496014-13-2/Benzenesulfonamide, 2,5-dimethoxy-N-3-quinolinyl-
- 1196059-70-7/1H-Benzimidazole-7-carboxamide, 2-[4-(2-pyridinyl)phenyl]-
- 1020100-62-2/1H-Pyrazole-3-carboxamide, 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-N-[2-(dimethylamino)-2-methyl-1-oxopropyl]-4-methyl-
- 1170700-86-3/4H-Imidazole-4-thione, 2-[5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-1H-pyrazol-3-yl]-1,5-dihydro-1,5,5-trimethyl-
- 1170700-70-5/4H-Imidazol-4-one, 2-[5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl]-1,5-dihydro-1,5,5-trimethyl-
- 859026-72-5/Benzamide, 3-([4,5'-bipyrimidin]-2-ylamino)-N-[4-[[(3S)-3-(dimethylamino)-1-pyrrolidinyl]methyl]-3-(trifluoromethyl)phenyl]-4-methyl-
- 926922-22-7/AP24226
- 460353-65-5/1,4-Dioxino[2,3-f]quinoline, 2-[[3,6-dihydro-4-(1H-indol-3-yl)-1(2H)-pyridinyl]methyl]-2,3-dihydro-8-methyl-, (2S)-
- 873693-47-1/Benzo[b]thiophene-2-ethanamine, N,N-dimethyl-3-[(1R)-1-(2-pyridinyl)ethyl]-
- 936106-68-2/8-Azabicyclo[3.2.1]octane, 8-[bis(2-chlorophenyl)methyl]-3-(2-pyridinyl)-, (3-exo)-
- 86718-70-9/(+)-Cisapride
- 886579-13-1/3-Quinolinecarboxamide, 1,2-dihydro-N-[(3-endo)-8-[(2S)-2-hydroxy-3-[4-(methylsulfonyl)-1-piperazinyl]propyl]-8-azabicyclo[3.2.1]oct-3-yl]-1-(1-methylethyl)-2-oxo-
- 1025717-75-2/L-Valine, N-[[8-(2-oxo-3-oxazolidinyl)-3-dibenzofuranyl]sulfonyl]-
- 946398-78-3/Benzamide, 3-chloro-4-[[(2R)-4-[4-fluoro-2-(trifluoromethyl)phenyl]-2-methyl-1-piperazinyl]sulfonyl]-
- 850176-30-6/ADL5747
- 866211-57-6/2H-Benzimidazol-2-one, 1-ethyl-3-[(1S,2R)-1-(3-fluorophenyl)-2-hydroxy-3-(methylamino)propyl]-1,3-dihydro-, hydrochloride (1:1)
- 866215-19-2/2H-Benzimidazol-2-one, 1-ethyl-3-[(1S,2R)-1-(3-fluorophenyl)-2-hydroxy-3-(methylamino)propyl]-1,3-dihydro-
- 871819-90-8/GSK554418A
- 871816-53-4/Methanone, [4-[(3-chlorophenyl)amino]-1-methyl-1H-pyrrolo[3,2-c]pyridin-7-yl]-4-morpholinyl-, hydrochloride (1:1)
- 936349-47-2/1H-Indole-2-propanoic acid, 3-[(1,1-dimethylethyl)thio]-1-[[4-(6-methoxy-3-pyridinyl)phenyl]methyl]-α,α-dimethyl-5-(2-pyridinylmethoxy)-
- 1147872-22-7/AM 103
- 895155-26-7/A-796260
- 1000279-69-5/A-867744
- 917837-54-8/[N-(4-Chlorophenyl)]-α-[(4-chlorophenyl)-aminomethylene]-3-methyl-5-isoxazoleacetamide
- 501684-93-1/NS 1738
- 929562-28-7/5-Thiazolemethanol, 2-[[4-fluoro-3-(trifluoromethyl)phenyl]amino]-4-(4-pyridinyl)-
- 357927-37-8/4-Pyridinecarbonitrile, 2-[(4S,5S)-5-(4-fluorophenyl)-5-(6-fluoro-3-pyridinyl)-4,5-dihydro-4-methyl-1H-imidazol-2-yl]-
- 623576-36-3/Spiro[6,9-methanobenzocyclooctene-11,3'-[1,2,5]thiadiazolidine], 2-[5-(4-fluorophenyl)-1-methyl-1H-pyrazol-3-yl]-5,6,7,8,9,10-hexahydro-5'-(2,2,2-trifluoroethyl)-, 1',1'-dioxide, (3'R,6S,9R)-